This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Sysmex Corporation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Eiya Tamada: Innovator in Cardiovascular Disease Risk Assessment
Introduction
Eiya Tamada is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medical technology, particularly in the assessment of cardiovascular disease risk. His innovative approach has the potential to improve patient outcomes and enhance preventive healthcare measures.
Latest Patents
Eiya Tamada holds a patent for a method titled "Method for determining onset risk of cardiovascular disease in subject, and method for determining vascular calcification in subject." This patent outlines a novel technique for assessing the risk of cardiovascular disease in individuals, which could lead to earlier interventions and better management of health.
Career Highlights
Eiya Tamada is currently associated with Sysmex Corporation, a company renowned for its advancements in medical diagnostics and laboratory testing. His work at Sysmex has allowed him to focus on innovative solutions that address critical health issues.
Collaborations
Eiya has collaborated with talented coworkers, including Maria Kiriyama and Elnaz Nakhaei. Their combined expertise contributes to the development of cutting-edge technologies in the medical field.
Conclusion
Eiya Tamada's contributions to cardiovascular disease risk assessment exemplify the impact of innovation in healthcare. His work not only advances medical technology but also holds promise for improving patient care and outcomes.